These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23357842)

  • 1. Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosis.
    Stallings VA; Mondick JT; Schall JI; Barrett JS; Wilson M; Mascarenhas MR
    Int J Clin Pharmacol Ther; 2013 Apr; 51(4):263-73. PubMed ID: 23357842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency.
    Mascarenhas MR; Mondick J; Barrett JS; Wilson M; Stallings VA; Schall JI
    J Clin Pharmacol; 2015 Aug; 55(8):854-65. PubMed ID: 25689042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: A randomized controlled trial.
    Stallings VA; Tindall AM; Mascarenhas MR; Maqbool A; Schall JI
    PLoS One; 2020; 15(5):e0232685. PubMed ID: 32384122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the 13C-triolein breath test for fat malabsorption in adult patients with cystic fibrosis.
    Ritz MA; Fraser RJ; Di Matteo AC; Greville H; Butler R; Cmielewski P; Davidson G
    J Gastroenterol Hepatol; 2004 Apr; 19(4):448-53. PubMed ID: 15012784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids.
    Kalivianakis M; Minich DM; Bijleveld CM; van Aalderen WM; Stellaard F; Laseur M; Vonk RJ; Verkade HJ
    Am J Clin Nutr; 1999 Jan; 69(1):127-34. PubMed ID: 9925134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
    Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation in an animal model of the carbon 13-labeled mixed triglyceride breath test for the detection of intestinal fat malabsorption.
    Kalivianakis M; Elstrodt J; Havinga R; Kuipers F; Stellaard F; Sauer PJ; Vonk RJ; Verkade HJ
    J Pediatr; 1999 Oct; 135(4):444-50. PubMed ID: 10518078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fat malabsorption in cystic fibrosis: comparison of quantitative fat assay and a novel assay using fecal lauric/behenic acid.
    Dorsey J; Buckley D; Summer S; Jandacek RJ; Rider T; Tso P; Narkewicz MR; Heubi JE
    J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):441-6. PubMed ID: 20179641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of impaired intestinal absorption of long-chain fatty acids: validation studies of a novel test in a rat model of fat malabsorption.
    Kalivianakis M; Minich DM; Havinga R; Kuipers F; Stellaard F; Vonk RJ; Verkade HJ
    Am J Clin Nutr; 2000 Jul; 72(1):174-80. PubMed ID: 10871577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipase inhibition attenuates the acute inhibitory effects of oral fat on food intake in healthy subjects.
    O'Donovan D; Feinle-Bisset C; Wishart J; Horowitz M
    Br J Nutr; 2003 Nov; 90(5):849-52. PubMed ID: 14667178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic Function in Chronic Pancreatitis: A Cohort Study Comparing 3 Methods of Detecting Fat Malabsorption and the Impact of Short-term Pancreatic Enzyme Replacement Therapy.
    Brownell JN; Schall JI; Stallings VA
    Pancreas; 2019 Sep; 48(8):1068-1078. PubMed ID: 31404029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients.
    Lark RK; Lester GE; Ontjes DA; Blackwood AD; Hollis BW; Hensler MM; Aris RM
    Am J Clin Nutr; 2001 Mar; 73(3):602-6. PubMed ID: 11237938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events.
    Bijvelds MJ; Bronsveld I; Havinga R; Sinaasappel M; de Jonge HR; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G646-53. PubMed ID: 15528257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the inhibition of dietary fat absorption by full versus divided doses of orlistat.
    Hussain Y; Güzelhan C; Odink J; van der Beek EJ; Hartmann D
    J Clin Pharmacol; 1994 Nov; 34(11):1121-5. PubMed ID: 7876405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of orlistat on the regulation of gallbladder contraction in man: a randomized double-blind placebo-controlled crossover study.
    Froehlich F; Hartmann D; Guezelhan C; Gonvers JJ; Jansen JB; Fried M
    Dig Dis Sci; 1996 Dec; 41(12):2404-8. PubMed ID: 9011450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between faecal pH and fat absorption in children with cystic fibrosis on a controlled diet and enzyme supplements dose.
    Calvo-Lerma J; Roca M; Boon M; Colombo C; de Koning B; Fornés-Ferrer V; Masip E; Garriga M; Bulfamante A; Asensio-Grau A; Andrés A; de Boeck K; Hulst J; Ribes-Koninckx C
    Pediatr Res; 2021 Jan; 89(1):205-210. PubMed ID: 32247283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of the lipase inhibitor orlistat with ethanol in healthy volunteers.
    Melia AT; Zhi J; Zelasko R; Hartmann D; Güzelhan C; Guerciolini R; Odink J
    Eur J Clin Pharmacol; 1998; 54(9-10):773-7. PubMed ID: 9923583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linoleic acid absorption from lipid supplements in patients with cystic fibrosis with pancreatic insufficiency and in control subjects.
    McKenna MC; Hubbard VS; Bieri JG
    J Pediatr Gastroenterol Nutr; 1985 Feb; 4(1):45-51. PubMed ID: 3981368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of orlistat, an inhibitor of dietary fat absorption, on the pharmacokinetics of beta-carotene in healthy volunteers.
    Zhi J; Melia AT; Koss-Twardy SG; Arora S; Patel IH
    J Clin Pharmacol; 1996 Feb; 36(2):152-9. PubMed ID: 8852391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.